Back to search

University of Washington

Engineering multiscale therapeutics for kidney disease

Abstract

dc:description.abstract

New therapies are urgently needed to address the growing chronic kidney disease epidemic. Nanoscale materials can enable precision drug delivery to kidney cells, improving the efficacy and safety profile of drug cargo. Renal progenitor cells can be engineered with nanotechnology to more efficiently regenerate lost kidney cells. Part I first motivates glomerular podocytes and proximal tubule cells as therapeutic targets in glomerular injury (Chapter 1). Nanoscale polymers that specifically target proximal tubules are identified (Chapter 2), and a new linker for programmed drug release (Chapter 3) and nanoparticles (Chapter 4) are developed for drug delivery to podocytes. Chapter 5 recommends new work to apply these platforms in therapeutic models. Part II begins with an introduction on renal progenitor cell biology (Chapter 7), and optimizes methods for non-viral gene delivery to these cells (Chapter 8). Chapter 9 recommends future work to use nanotechnology to promote renal progenitor cell survival and function.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Liu, Gary
Advisor dc:contributor.advisor
  • Pun, Suzie H

Subjects

dc:subject × 8

Rights

dc:rights
Statement dc:rights
  • CC BY
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1773/44044

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Liu, Gary. Engineering multiscale therapeutics for kidney disease. 2019. http://hdl.handle.net/1773/44044